1. Home
  2. OVID vs GLU Comparison

OVID vs GLU Comparison

Compare OVID & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • GLU
  • Stock Information
  • Founded
  • OVID 2014
  • GLU 2004
  • Country
  • OVID United States
  • GLU United States
  • Employees
  • OVID N/A
  • GLU N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • GLU Finance/Investors Services
  • Sector
  • OVID Health Care
  • GLU Finance
  • Exchange
  • OVID Nasdaq
  • GLU Nasdaq
  • Market Cap
  • OVID 117.3M
  • GLU 108.3M
  • IPO Year
  • OVID 2017
  • GLU N/A
  • Fundamental
  • Price
  • OVID $1.32
  • GLU $18.23
  • Analyst Decision
  • OVID Strong Buy
  • GLU
  • Analyst Count
  • OVID 4
  • GLU 0
  • Target Price
  • OVID $3.13
  • GLU N/A
  • AVG Volume (30 Days)
  • OVID 1.7M
  • GLU 12.4K
  • Earning Date
  • OVID 11-13-2025
  • GLU 01-01-0001
  • Dividend Yield
  • OVID N/A
  • GLU 8.60%
  • EPS Growth
  • OVID N/A
  • GLU N/A
  • EPS
  • OVID N/A
  • GLU 0.62
  • Revenue
  • OVID $6,651,000.00
  • GLU N/A
  • Revenue This Year
  • OVID $1,081.80
  • GLU N/A
  • Revenue Next Year
  • OVID N/A
  • GLU N/A
  • P/E Ratio
  • OVID N/A
  • GLU $22.50
  • Revenue Growth
  • OVID 1070.95
  • GLU N/A
  • 52 Week Low
  • OVID $0.24
  • GLU $11.61
  • 52 Week High
  • OVID $2.01
  • GLU $15.40
  • Technical
  • Relative Strength Index (RSI)
  • OVID 41.52
  • GLU 53.92
  • Support Level
  • OVID $1.27
  • GLU $17.93
  • Resistance Level
  • OVID $1.44
  • GLU $18.30
  • Average True Range (ATR)
  • OVID 0.10
  • GLU 0.23
  • MACD
  • OVID -0.04
  • GLU -0.01
  • Stochastic Oscillator
  • OVID 14.29
  • GLU 70.90

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

Share on Social Networks: